Christopher Durant Turner

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Nathan McConarty, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Durant Turner:

Form 4 holding Chief Medical Officer

Nuvalent, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
17,500
Estimated value
Report date
07 Jan 2026
Price
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount

Insider Reports Filed by Christopher Durant Turner

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .